logo
搜索
菜单

Bioavailab的搜索结果

当前1/4页
排序: 总浏览数
5.6: Compound Administration I 15:06 min
5.6: Compound Administration I
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs 10.3791/2460-v
Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
3.8: First Pass Effect 01:12 min
3.8: First Pass Effect
1.9: Routes of Drug Administration: Overview 01:22 min
1.9: Routes of Drug Administration: Overview
3.6: Factors Influencing Bioavailability: First-Pass Elimination 01:23 min
3.6: Factors Influencing Bioavailability: First-Pass Elimination
3.27: Rational Dosage Regimen: Maintenance Dose and Loading Dose 01:24 min
3.27: Rational Dosage Regimen: Maintenance Dose and Loading Dose
1.1: Biopharmaceutics and Pharmacokinetics: Overview 01:28 min
1.1: Biopharmaceutics and Pharmacokinetics: Overview
3.5: Bioavailability: Overview 01:13 min
3.5: Bioavailability: Overview
12.6: Crossover Experiments 01:16 min
12.6: Crossover Experiments
3.29: Prodrugs 01:30 min
3.29: Prodrugs
3.25: Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH 01:21 min
3.25: Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.11: Routes of Drug Administration: Parenteral 01:25 min
1.11: Routes of Drug Administration: Parenteral
1.4: Drug Nomenclature 01:17 min
1.4: Drug Nomenclature
3.2: Drug Absorption: Overview 01:17 min
3.2: Drug Absorption: Overview
3.4: Drug Delivery: Enteral Route 01:18 min
3.4: Drug Delivery: Enteral Route
3.7: Bioequivalence: Overview 01:16 min
3.7: Bioequivalence: Overview
3.23: Factors Affecting Dissolution: Particle Size and Effective Surface Area 01:23 min
3.23: Factors Affecting Dissolution: Particle Size and Effective Surface Area
6.7: Adrenergic Agonists: Mixed-Action Agents 01:28 min
6.7: Adrenergic Agonists: Mixed-Action Agents
4.6: Volume of Distribution 01:20 min
4.6: Volume of Distribution
3.19: Factors Influencing Drug Absorption: Drug Dissolution 01:27 min
3.19: Factors Influencing Drug Absorption: Drug Dissolution
返回顶部